| UniProt ID | CPNS1_HUMAN | |
|---|---|---|
| UniProt AC | P04632 | |
| Protein Name | Calpain small subunit 1 | |
| Gene Name | CAPNS1 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 268 | |
| Subcellular Localization | Cytoplasm. Cell membrane. Translocates to the plasma membrane upon calcium binding.. | |
| Protein Description | Regulatory subunit of the calcium-regulated non-lysosomal thiol-protease which catalyzes limited proteolysis of substrates involved in cytoskeletal remodeling and signal transduction.. | |
| Protein Sequence | MFLVNSFLKGGGGGGGGGGGLGGGLGNVLGGLISGAGGGGGGGGGGGGGGGGGGGGTAMRILGGVISAISEAAAQYNPEPPPPRTHYSNIEANESEEVRQFRRLFAQLAGDDMEVSATELMNILNKVVTRHPDLKTDGFGIDTCRSMVAVMDSDTTGKLGFEEFKYLWNNIKRWQAIYKQFDTDRSGTICSSELPGAFEAAGFHLNEHLYNMIIRRYSDESGNMDFDNFISCLVRLDAMFRAFKSLDKDGTGQIQVNIQEWLQLTMYS | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 1 | Sulfoxidation | -------MFLVNSFL -------CCCCCCCC | 5.45 | 28183972 | |
| 1 | Acetylation | -------MFLVNSFL -------CCCCCCCC | 5.45 | 19413330 | |
| 6 | Phosphorylation | --MFLVNSFLKGGGG --CCCCCCCCCCCCC | 25.20 | 28355574 | |
| 9 | Methylation | FLVNSFLKGGGGGGG CCCCCCCCCCCCCCC | 54.20 | - | |
| 9 | Acetylation | FLVNSFLKGGGGGGG CCCCCCCCCCCCCCC | 54.20 | 88577 | |
| 9 | Sumoylation | FLVNSFLKGGGGGGG CCCCCCCCCCCCCCC | 54.20 | - | |
| 34 | Phosphorylation | NVLGGLISGAGGGGG HHHHHHHCCCCCCCC | 27.86 | 20068231 | |
| 34 | O-linked_Glycosylation | NVLGGLISGAGGGGG HHHHHHHCCCCCCCC | 27.86 | 23301498 | |
| 57 | Phosphorylation | GGGGGGGTAMRILGG CCCCCHHHHHHHHHH | 22.13 | 28857561 | |
| 57 | O-linked_Glycosylation | GGGGGGGTAMRILGG CCCCCHHHHHHHHHH | 22.13 | 23301498 | |
| 59 | Sulfoxidation | GGGGGTAMRILGGVI CCCHHHHHHHHHHHH | 2.48 | 28465586 | |
| 67 | Acetylation | RILGGVISAISEAAA HHHHHHHHHHHHHHH | 19.69 | 19608861 | |
| 67 | Ubiquitination | RILGGVISAISEAAA HHHHHHHHHHHHHHH | 19.69 | 19608861 | |
| 67 | Phosphorylation | RILGGVISAISEAAA HHHHHHHHHHHHHHH | 19.69 | 24719451 | |
| 70 | Phosphorylation | GGVISAISEAAAQYN HHHHHHHHHHHHHHC | 22.39 | 27251275 | |
| 85 | Phosphorylation | PEPPPPRTHYSNIEA CCCCCCCCCCCCCCC | 30.82 | 21945579 | |
| 87 | Phosphorylation | PPPPRTHYSNIEANE CCCCCCCCCCCCCCC | 11.64 | 21945579 | |
| 88 | Phosphorylation | PPPRTHYSNIEANES CCCCCCCCCCCCCCC | 24.59 | 21945579 | |
| 99 | Methylation | ANESEEVRQFRRLFA CCCCHHHHHHHHHHH | 32.95 | - | |
| 126 | Ubiquitination | ELMNILNKVVTRHPD HHHHHHHHHHHHCCC | 34.34 | - | |
| 135 | Ubiquitination | VTRHPDLKTDGFGID HHHCCCCCCCCCCHH | 52.53 | 21906983 | |
| 135 | Acetylation | VTRHPDLKTDGFGID HHHCCCCCCCCCCHH | 52.53 | 25953088 | |
| 144 | S-nitrosylation | DGFGIDTCRSMVAVM CCCCHHCCCCEEEHH | 2.41 | 2212679 | |
| 146 | Phosphorylation | FGIDTCRSMVAVMDS CCHHCCCCEEEHHCC | 21.54 | - | |
| 147 | Sulfoxidation | GIDTCRSMVAVMDSD CHHCCCCEEEHHCCC | 0.86 | 21406390 | |
| 151 | Sulfoxidation | CRSMVAVMDSDTTGK CCCEEEHHCCCCCCC | 2.69 | 30846556 | |
| 153 | Phosphorylation | SMVAVMDSDTTGKLG CEEEHHCCCCCCCCC | 20.82 | - | |
| 156 | Phosphorylation | AVMDSDTTGKLGFEE EHHCCCCCCCCCHHH | 36.99 | - | |
| 158 | Ubiquitination | MDSDTTGKLGFEEFK HCCCCCCCCCHHHHH | 43.26 | - | |
| 165 | Ubiquitination | KLGFEEFKYLWNNIK CCCHHHHHHHHHHHH | 42.59 | - | |
| 172 | Acetylation | KYLWNNIKRWQAIYK HHHHHHHHHHHHHHH | 50.10 | 25953088 | |
| 172 | Ubiquitination | KYLWNNIKRWQAIYK HHHHHHHHHHHHHHH | 50.10 | 21890473 | |
| 172 | 2-Hydroxyisobutyrylation | KYLWNNIKRWQAIYK HHHHHHHHHHHHHHH | 50.10 | - | |
| 178 | Phosphorylation | IKRWQAIYKQFDTDR HHHHHHHHHHHCCCC | 11.18 | 25884760 | |
| 179 | Acetylation | KRWQAIYKQFDTDRS HHHHHHHHHHCCCCC | 38.07 | 19608861 | |
| 179 | Malonylation | KRWQAIYKQFDTDRS HHHHHHHHHHCCCCC | 38.07 | 26320211 | |
| 179 | 2-Hydroxyisobutyrylation | KRWQAIYKQFDTDRS HHHHHHHHHHCCCCC | 38.07 | - | |
| 179 | Ubiquitination | KRWQAIYKQFDTDRS HHHHHHHHHHCCCCC | 38.07 | 21890473 | |
| 218 | Phosphorylation | NMIIRRYSDESGNMD HHHHHHHCCCCCCCC | 32.84 | 21712546 | |
| 224 | Sulfoxidation | YSDESGNMDFDNFIS HCCCCCCCCHHHHHH | 6.57 | 30846556 | |
| 244 | Acetylation | DAMFRAFKSLDKDGT HHHHHHHHCCCCCCC | 49.47 | 27452117 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of CPNS1_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CPNS1_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CPNS1_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| CSPG4_HUMAN | CSPG4 | physical | 22939629 | |
| TRAF5_HUMAN | TRAF5 | physical | 21988832 | |
| STAT3_HUMAN | STAT3 | physical | 21988832 | |
| PRGC1_HUMAN | PPARGC1A | physical | 21988832 | |
| AL7A1_HUMAN | ALDH7A1 | physical | 22863883 | |
| APEX1_HUMAN | APEX1 | physical | 22863883 | |
| DCPS_HUMAN | DCPS | physical | 22863883 | |
| ISOC1_HUMAN | ISOC1 | physical | 22863883 | |
| METK2_HUMAN | MAT2A | physical | 22863883 | |
| MAT2B_HUMAN | MAT2B | physical | 22863883 | |
| LIS1_HUMAN | PAFAH1B1 | physical | 22863883 | |
| PAK2_HUMAN | PAK2 | physical | 22863883 | |
| PDIA4_HUMAN | PDIA4 | physical | 22863883 | |
| PP1A_HUMAN | PPP1CA | physical | 22863883 | |
| PLPHP_HUMAN | PROSC | physical | 22863883 | |
| 1433E_HUMAN | YWHAE | physical | 22863883 | |
| 1433G_HUMAN | YWHAG | physical | 22863883 | |
| 1433F_HUMAN | YWHAH | physical | 22863883 | |
| 1433T_HUMAN | YWHAQ | physical | 22863883 | |
| 1433Z_HUMAN | YWHAZ | physical | 22863883 | |
| ATRAP_HUMAN | AGTRAP | physical | 25416956 | |
| UBP1_HUMAN | USP1 | physical | 23589330 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND MASS SPECTROMETRY. | |
| "Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-179, AND MASS SPECTROMETRY. | |